Expert Commentary: Review of Treatments for Short Stature
Mitchell Geffner, MD
Kurt Midyett, MD
Kurt Midyett, MD
Expert Comentary: Clinical Trial Update
First-Year Height Velocities with Once-Daily and Twice-Daily Dosing of rhIGF-1 in Prepubertal Children with Primary IGF-1 Deficiency
First-Year Height Velocities with Once-Daily and Twice-Daily Dosing of rhIGF-1 in Prepubertal Children with Primary IGF-1 Deficiency
Kurt Midyett, MD
Alan Rogol, MD
Alan Rogol, MD
High-Dose Octreotide LAR Is Effective and Safe in Patients with Acromegaly Inadequately Controlled by Conventional Somatostatin Analog Therapy: A Randomized, Controlled Trial
Gherardo Mazziotti, MD
Craniofacial and Extremity Growth Evaluation in Patients with Turner Syndrome during Growth Hormone Therapy
Maria Estela Justamante de Faria, MD
Genetic Polymorphisms Associated with Changes in Serum IGF-I in Prepubertal Children with Growth Hormone Deficiency (GHD) or Turner Syndrome (TS) after One Month of Growth Hormone (GH) Therapy: The PREDICT Study Introducing Pharmacogenomics into Clini
PE Clayton, P Chatelain, V Peterkova, A Belgorosky, D Veimo, A Ferrandez, M Tuefferd, J Dauvillier, L Tato, and PREDICT Investigators
Four Year Efficacy and Safety Data of Treatment with Omnitrope® 5 mg/ml Lyophilized Formulation in Children with Growth Failure Due to Growth Hormone Deficiency
F Peter, T Romer, B Koehler, E Solyom, M Walczak, A Muzsnai, A Rudzka-Kocjan, E Kaluza-Guzikowska, E Petriczko, and PH Saenger
Growth Hormone Administration Reduces Visceral Adiposity and HsCRP in Patients with Growth Hormone Deficiency Following Cure of Acromegaly: A Randomized, Placebo-Controlled Study
Karen K. Miller, MD